A mother heavily pregnant with her fourth child had her symptoms dismissed as tinnitus after complaining of hearing loss, balance issues and numbness in her face. But after seeking a second opinion, ...
WHEN Kerry Sharples started suffering pain in her left year last year, she thought nothing of it and assumed it was merely a ...
Meningiomas can lead to neurologic deficits including progressive visual loss due to the nerve's complex intra-orbital, intracanalicular, and intracranial anatomy. This Research Topic explores the ...
While meningioma, a tumor inside the head, is usually benign, there are interesting symptoms that you should be aware of. A meningioma grows inside the membrane that surrounds the brain and spinal ...
Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the meninges, the membranes that surround the brain. In most cases, a meningioma ...
Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...
Deaths from both causes are down, but they still eclipse all other causes, according to new statistics. By Nina Agrawal Despite gains in treatment, cardiovascular disease remains the leading cause of ...
A LARGE cohort study shows that meningiomas develop years later in a significant minority of survivors, with higher risks linked to treatment at earlier ages, radiation exposure, and certain ...
The FDA approved a label change for the birth control shot depot medroxyprogesterone acetate (Depo-Provera), which now warns about the risk of meningioma, according to a letter posted on the agency ...
The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...
The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.